CORRESP Filing
Bluejay Diagnostics, Inc.
Date: May 5, 2025 · CIK: 0001704287 · Accession: 0001213900-25-039695
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-286834
Letter
Bluejay Diagnostics, Inc.
Massachusetts Avenue, Suite 203
Acton, MA 01720
May 5, 2025
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
F Street, N.E.
Washington, D.C. 20549
Re: Bluejay Diagnostics, Inc.
Registration Statement on Form S-3
File No. 333-286834
Request for Acceleration of Effectiveness
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Bluejay Diagnostics, Inc. (the " Company ") hereby requests that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced Registration Statement on Form S-3 (the " Registration Statement "), and declare the Registration Statement effective as of 4:30 p.m., Eastern Time, on May 7, 2025, or as soon thereafter as is practicable, or at such other time as the Company may orally request by telephone. The Company hereby authorizes each of Brian O'Fahey and Helen Ferrall of Hogan Lovells US LLP, counsel to the Company, to make such request on its behalf.
Please feel free to direct any questions or comments concerning this request to Mr. O'Fahey at (202) 637-6541 or Ms. Ferrall at (202) 804-7696, and once the Registration Statement has been declared effective, please notify Mr. O'Fahey or Ms. Ferrall by calling either of them at the same phone number.
Very
truly yours,
Bluejay
Diagnostics, Inc.
Show Raw Text
CORRESP 1 filename1.htm Bluejay Diagnostics, Inc. 360 Massachusetts Avenue, Suite 203 Acton, MA 01720 May 5, 2025 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Bluejay Diagnostics, Inc. Registration Statement on Form S-3 File No. 333-286834 Request for Acceleration of Effectiveness Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Bluejay Diagnostics, Inc. (the " Company ") hereby requests that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced Registration Statement on Form S-3 (the " Registration Statement "), and declare the Registration Statement effective as of 4:30 p.m., Eastern Time, on May 7, 2025, or as soon thereafter as is practicable, or at such other time as the Company may orally request by telephone. The Company hereby authorizes each of Brian O'Fahey and Helen Ferrall of Hogan Lovells US LLP, counsel to the Company, to make such request on its behalf. Please feel free to direct any questions or comments concerning this request to Mr. O'Fahey at (202) 637-6541 or Ms. Ferrall at (202) 804-7696, and once the Registration Statement has been declared effective, please notify Mr. O'Fahey or Ms. Ferrall by calling either of them at the same phone number. Very truly yours, Bluejay Diagnostics, Inc. /s/ Neil Dey By: Neil Dey Title: President and Chief Executive Officer